Arch Biopartners Inc. ARCH.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -343.30K | -379.80K | -1.12M | -195.90K | -175.20K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -32.30K | 301.00K | 508.90K | 8.60K | 257.30K |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -375.60K | -78.80K | -609.70K | -187.20K | 82.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 65.70K | 32.60K | 106.90K | -- |
| Total Debt Repaid | -38.00K | -- | -242.90K | -- | -252.30K |
| Issuance of Common Stock | 124.00K | 475.00K | 1.06M | -- | 296.00K |
| Repurchase of Common Stock | -- | -- | -- | -14.30K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 62.10K | 394.20K | 611.10K | 67.20K | 31.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -313.40K | 315.40K | 1.50K | -120.10K | 113.80K |